SCHEMBL15624209

SCHEMBL15624209

Cn1c(/C=C/c2ccc(N(c3ccccc3)c3ccc(/C=C/c4n(C)c5ccccc5[n+]4C)cc3)cc2)[n+](C)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.51
▸ RAB9A P51151 7/20 0.43
▸ HTT P42858 5/20 0.43
▸ LMNA P02545 4/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ ACHE P22303 4/20 0.40
▸ BCHE P06276 3/20 0.40
▸ INSR P06213 2/20 0.39
▸ KMT2A Q03164 7/20 0.39
▸ MEN1 O00255 6/20 0.39
▸ MAPT P10636 6/20 0.39
▸ NPC1 O15118 6/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ PKM P14618 4/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ POLB P06746 3/20 0.39
▸ NPSR1 Q6W5P4 3/20 0.39
▸ THRB P10828 2/20 0.39
▸ RECQL P46063 2/20 0.39
▸ BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15624210 0.97 APP (0.47) APPRAB9AHTTLMNAKDM4E
SCHEMBL13133372 0.88 RAB9A (0.57) APPRAB9AHTTLMNAKDM4E
SCHEMBL3814983 0.82 RAB9A (0.42) APPRAB9AHTTLMNAKDM4E
SCHEMBL4625097 0.82 ERAP1 (0.38) RAB9AHTTLMNAKDM4EACHE
SCHEMBL3837492 0.80 RAB9A (0.41) APPRAB9AHTTLMNAKDM4E
SCHEMBL3835590 0.80 RAB9A (0.41) APPRAB9AHTTLMNAKDM4E
SCHEMBL13294096 0.80 MEN1 (0.42) APPRAB9AHTTLMNAKDM4E
SCHEMBL3834687 0.79 RAB9A (0.40) APPRAB9AHTTLMNAKDM4E
SCHEMBL3834682 0.79 RAB9A (0.40) APPRAB9AHTTLMNAKDM4E
SCHEMBL3838343 0.75 MEN1 (0.39) APPRAB9AHTTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014044757-A1 CATIONIC TRIPHENYLAMINE DERIVATIVES ACTIVABLE BY VISIBLE AND INFRA RED LIGHT FOR INDUCING AND IMAGING APOPTOSIS IN CANCER CELLS INSTITUT CURIE (FR) 2014-03-27 — — WO disclosed
EP-2711366-A1 Cationic triphenylamine derivatives activable by visible and Infra Red light for inducing and imaging apoptosis in cancer cells Institut Curie (FR) 2014-03-26 — — EP disclosed
Send feedback